Peña-Bautista, C.; Álvarez-Sánchez, L.; Ferrer, I.; López-Nogueroles, M.; Cañada-Martínez, A.J.; Oger, C.; Galano, J.-M.; Durand, T.; Baquero, M.; Cháfer-Pericás, C.
Lipid Peroxidation Assessment in Preclinical Alzheimer Disease Diagnosis. Antioxidants 2021, 10, 1043.
https://doi.org/10.3390/antiox10071043
AMA Style
Peña-Bautista C, Álvarez-Sánchez L, Ferrer I, López-Nogueroles M, Cañada-Martínez AJ, Oger C, Galano J-M, Durand T, Baquero M, Cháfer-Pericás C.
Lipid Peroxidation Assessment in Preclinical Alzheimer Disease Diagnosis. Antioxidants. 2021; 10(7):1043.
https://doi.org/10.3390/antiox10071043
Chicago/Turabian Style
Peña-Bautista, Carmen, Lourdes Álvarez-Sánchez, Inés Ferrer, Marina López-Nogueroles, Antonio José Cañada-Martínez, Camille Oger, Jean-Marie Galano, Thierry Durand, Miguel Baquero, and Consuelo Cháfer-Pericás.
2021. "Lipid Peroxidation Assessment in Preclinical Alzheimer Disease Diagnosis" Antioxidants 10, no. 7: 1043.
https://doi.org/10.3390/antiox10071043
APA Style
Peña-Bautista, C., Álvarez-Sánchez, L., Ferrer, I., López-Nogueroles, M., Cañada-Martínez, A. J., Oger, C., Galano, J.-M., Durand, T., Baquero, M., & Cháfer-Pericás, C.
(2021). Lipid Peroxidation Assessment in Preclinical Alzheimer Disease Diagnosis. Antioxidants, 10(7), 1043.
https://doi.org/10.3390/antiox10071043